Refine Search Results
Search Results Table
| Law | Result Summary | |
|---|---|---|
| Part I Title XV Chapter 94C Section 18D |
Duty of pharmacist dispensing an opioid to inform of adverse risks and to offer to dispense opioid antagonist
[ Text of section added by 2024, 140, Sec ... potential adverse risks of the prescription opioid and shall offer to dispense an opioid antagonist to the patient, and where applicable, to ... |
|
| Part I Title XV Chapter 94C Section 19B |
Dispensing, possessing and administrating opioid antagonist
who, acting in good faith, administers an opioid antagonist to an individual appearing to experience an opioid-related overdose shall not, as a result ... |
|
| Part III Title V Chapter 260 Section 2F |
Prescription opioids actions
cause of action concerning prescription opioids brought against Purdue Pharma L.P., Purdue ... This section shall apply regardless of when any such action or claim shall have accrued ... |
|
| Part I Title XVII Chapter 118E Section 10X |
Coverage for prescribed, ordered or dispensed opioid antagonists
shall provide coverage and reimbursement for an opioid antagonist used in the reversal of overdoses caused by opioids as a medical benefit when dispensed by the ... |
|
| Part I Title XXII Chapter 175 Section 47AAA |
Coverage for prescribed, ordered or dispensed opioid antagonists
shall provide coverage and reimbursement for an opioid antagonist used in the reversal of overdoses caused by opioids as a medical benefit when dispensed by the ... |
|
| Part I Title XXII Chapter 176A Section 8BBB |
Coverage for prescribed, ordered or dispensed opioid antagonists
shall provide coverage and reimbursement for an opioid antagonist used in the reversal of overdoses caused by opioids as a medical benefit when dispensed by the ... |
|
| Part I Title XXII Chapter 176B Section 4BBB |
Coverage for prescribed, ordered or dispensed opioid antagonists
shall provide coverage and reimbursement for an opioid antagonist used in the reversal of overdoses caused by opioids as a medical benefit when dispensed by the ... |
|
| Part I Title XXII Chapter 176G Section 4TT |
Coverage for prescribed, ordered or dispensed opioid antagonists
shall provide coverage and reimbursement for an opioid antagonist used in the reversal of overdoses caused by opioids as a medical benefit when dispensed by the ... |
|
| Part I Title IV Chapter 32A Section 17X |
Coverage for prescribed, ordered or dispensed opioid antagonists; reimbursement
shall provide coverage and reimbursement for an opioid antagonist used in the reversal of overdoses caused by opioids as a medical benefit when dispensed by the ... |
|
| Part I Title XV Chapter 94C Section 18C |
Patient education required before issuance of opioid prescription
Prior to issuing a prescription for an opioid contained in Schedule II of section 3, a ... with a the patient regarding the quantity of the opioid and a patient's option to fill the ... |
|
| Part I Title XXII Chapter 176G Section 4Y |
Coverage for abuse deterrent opioid drug products
shall provide coverage for abuse deterrent opioid drug products listed on the formulary ... not less favorable than non-abuse deterrent opioid drug products that are covered by an ... |
|
| Part I Title IV Chapter 32A Section 17L |
Coverage for abuse deterrent opioid drug products
shall provide coverage for abuse deterrent opioid drug products listed on the formulary ... not less favorable than non-abuse deterrent opioid drug products that are covered by the ... |
|
| Part I Title XXII Chapter 176B Section 4GG |
Coverage for abuse deterrent opioid drug products
shall provide coverage for abuse deterrent opioid drug products listed on the formulary ... not less favorable than non-abuse deterrent opioid drug products that are covered by an ... |
|
| Part I Title XXII Chapter 175 Section 47EE |
Coverage for abuse deterrent opioid drug products
shall provide coverage for abuse deterrent opioid drug products listed on the formulary ... not less favorable than non-abuse deterrent opioid drug products that are covered by such ... |
|
| Part I Title XXII Chapter 176A Section 8GG |
Coverage for abuse deterrent opioid drug products
shall provide coverage for abuse deterrent opioid drug products listed on the formulary ... not less favorable than non-abuse deterrent opioid drug products that are covered by the ... |
|
| Part I Title XV Chapter 94C Section 19B 1/2 |
Exchange of naloxone or other opioid antagonist between registered entities
convey or exchange naloxone or another opioid antagonist approved by the department to or ... of unexpired naloxone or other approved opioid antagonist; provided, however, that such an ... |
|
| Part I Title XV Chapter 94C Section 6A |
Licensure of certain corporate entities with patients receiving opioid agonist therapy; best practice guidance for practitioners
than 300 patients receiving treatment for opioid dependency in the form of opioid agonist therapy provided by physicians who are ... |
|
| Part I Title XV Chapter 94C Section 19D1/2 |
Substance use disorder treatment facility; dispense of opioid antagonist to patient or a legal guardian; promulgation of regulations
who has: (i) a history of using opioids; (ii) been diagnosed with opioid use disorder; or (iii) experienced an opioid-related ... |
|
| Part I Title XV Chapter 94C Section 19C |
High opiate overdose area pharmacies required to maintain continuous supply of naloxone rescue kits or opioid antagonist medications
if the supply or stock of opioid antagonist doses is insufficient to enable compliance with maintaining a continuous supply of opioid antagonists |
|
| Part I Title XVI Chapter 112 Section 12FF |
Immunity of person administering naloxone or other opioid antagonist to person experiencing opiate-related overdose
by administering naloxone or any other opioid antagonist, as defined in section 19B of ... |
|
| Part I Title XVI Chapter 111 Section 25J1/2 |
Intervention prior to discharge from acute-care hospital or satellite emergency facility to reduce risk of subsequent harm and fatality following opioid-related overdose
a history of or is actively using opioids; (ii) been diagnosed with opioid use disorder; or (iii) experienced an opioid-related overdose, the acute care hospital ... |
|
| Part I Title XVIII Chapter 127 Section 17B |
Medication-assisted treatment for opioid use disorder for state detainees or prisoners at certain facilities
shall offer medication-assisted treatment for opioid use disorder to a state detainee or ... use in medication-assisted treatment for opioid use disorder; provided however, that such ... |
|
| Part I Title XXII Chapter 175 Section 122B |
Discrimination based on having prescription for or purchase or possession of opioid antagonist prohibited; life insurance policies
[ Text of section added by 2024, 285, Sec. 22 effective November 20, 2024 ... for, purchased or otherwise possessed an opioid antagonist, as defined in section 19B of ... |
|
| Part I Title XVIII Chapter 127 Section 17C |
Re-entry treatment plan for state detainee or prisoner requiring treatment for opioid use disorder
or prisoner requires treatment for opioid use disorder, the qualified addiction specialist ... and Drug Administration for use in medication-assisted treatment for opioid use disorder ... |
|
| Part I Title XVII Chapter 118E Section 10I |
Coverage for administration of all federal Food and Drug Administration approved drugs for opioid or alcohol dependence treatment
approved drugs for the treatment of opioid or alcohol dependence and shall establish ... For the purposes of this section, ''clinical stabilization services'' shall mean a 24&ndash ... |
|